MResult’s teams helped Fortune-listed companies leverage AI innovatively to streamline processes, reduce human intervention & create better interactions between the organization & clients.
Organizations that are agile and lean create more value for their customers. MResult partnered with two Fortune-listed biopharma companies to create AI- and ML-based solutions that empowered teams to be nimble and innovative.
A Fortune 100 biopharma company wanted to:
A Fortune 500 biopharma company wanted to:
The MLabs teams put their expertise to work, breaking down the problem, identifying the gaps and innovating to address the customer’s pain points using custom, state-of-the-art AI and ML models.
The team partnered with the F100 biopharma company to:
For the Fortune 500 company, the MLabs team built a one-stop AI-powered chatbot that could:
Once the solutions were implemented, the F100 biopharma teams were able to:
Clients were able to gain critical, actionable insights on forecasting, improve the accuracy of decisions and ramp up internal user support quickly and efficiently.
Save time by accessing the application-based self-serve analytics model easily
Improve the accuracy of forecasting through additional insights gained by comparing forecasting methods based on a wider range of custom requirements.
Improve process efficiency for the RM&C team based on query-related insights & demonstrate an almost-immediate drop in the number of users needing agent support for low- to low-medium-risk RM&C complaints.
The F500 biopharma company was able to: